Top compounds associated with response to DPY19L3


Feature Type Standardized
Nominal ANOVA
mRNA FK866 GDSC1000 pan-cancer AAC 0.11 0.001
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA austocystin d CTRPv2 pan-cancer AAC 0.12 0.001
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.11 0.002
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA BX-912 GDSC1000 pan-cancer AAC 0.099 0.002
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA KIN001-055 GDSC1000 pan-cancer AAC -0.11 0.002
Download CSV